US Patent Issued to H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, MODULATION THERAPEUTICS, WAKE FOREST UNIVERSITY HEALTH SCIENCES on Dec. 30 for "Radiotherapeutic and companion imaging agents to target MC1R" (Florida, North Carolina Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,329, issued on Dec. 30, was assigned to H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC. (Tampa, Fla.), MODULATION THERAPEUTICS INC. (Morgantown, W.va.) and WAKE FOREST UNIVERSITY HEALTH SCIENCES (Winston Salem, N.C.).

"Radiotherapeutic and companion imaging agents to target MC1R" was invented by David Morse (Tampa, Fla.), Robert Gillies (Tampa, Fla.), Mark Mclaughlin (Tampa, Fla.), Thaddeus Wadas (Winston-Salem, N.C.), Hyun Joo Kil (Lutz, Fla.) and Narges Tafreshi (Tampa, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The subject matter disclosed herein relates generally to cancer therapy and to anticancer compounds and imaging agents....